185 related articles for article (PubMed ID: 28421466)
1. Parathyroid Diseases and T Cells.
Neale Weitzmann M; Pacifici R
Curr Osteoporos Rep; 2017 Jun; 15(3):135-141. PubMed ID: 28421466
[TBL] [Abstract][Full Text] [Related]
2. T cells potentiate PTH-induced cortical bone loss through CD40L signaling.
Gao Y; Wu X; Terauchi M; Li JY; Grassi F; Galley S; Yang X; Weitzmann MN; Pacifici R
Cell Metab; 2008 Aug; 8(2):132-45. PubMed ID: 18680714
[TBL] [Abstract][Full Text] [Related]
3. Disruption of PTH receptor 1 in T cells protects against PTH-induced bone loss.
Tawfeek H; Bedi B; Li JY; Adams J; Kobayashi T; Weitzmann MN; Kronenberg HM; Pacifici R
PLoS One; 2010 Aug; 5(8):e12290. PubMed ID: 20808842
[TBL] [Abstract][Full Text] [Related]
4. Bone and the Immune System.
Weitzmann MN
Toxicol Pathol; 2017 Oct; 45(7):911-924. PubMed ID: 29046115
[TBL] [Abstract][Full Text] [Related]
5. Effect of interleukin-17 on nitric oxide production and osteoclastic bone resorption: is there dependency on nuclear factor-kappaB and receptor activator of nuclear factor kappaB (RANK)/RANK ligand signaling?
Van Bezooijen RL; Papapoulos SE; Löwik CW
Bone; 2001 Apr; 28(4):378-86. PubMed ID: 11336918
[TBL] [Abstract][Full Text] [Related]
6. Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-kappab ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism.
Stilgren LS; Rettmer E; Eriksen EF; Hegedüs L; Beck-Nielsen H; Abrahamsen B
Bone; 2004 Jul; 35(1):256-65. PubMed ID: 15207766
[TBL] [Abstract][Full Text] [Related]
7. IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice.
O'Brien CA; Jilka RL; Fu Q; Stewart S; Weinstein RS; Manolagas SC
Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E784-93. PubMed ID: 15956054
[TBL] [Abstract][Full Text] [Related]
8. The Proteasome Inhibitor Carfilzomib Suppresses Parathyroid Hormone-induced Osteoclastogenesis through a RANKL-mediated Signaling Pathway.
Yang Y; Blair HC; Shapiro IM; Wang B
J Biol Chem; 2015 Jul; 290(27):16918-28. PubMed ID: 25979341
[TBL] [Abstract][Full Text] [Related]
9. IL-17 Receptor Signaling in Osteoblasts/Osteocytes Mediates PTH-Induced Bone Loss and Enhances Osteocytic RANKL Production.
Li JY; Yu M; Tyagi AM; Vaccaro C; Hsu E; Adams J; Bellido T; Weitzmann MN; Pacifici R
J Bone Miner Res; 2019 Feb; 34(2):349-360. PubMed ID: 30399207
[TBL] [Abstract][Full Text] [Related]
10. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells.
Kondo H; Guo J; Bringhurst FR
J Bone Miner Res; 2002 Sep; 17(9):1667-79. PubMed ID: 12211438
[TBL] [Abstract][Full Text] [Related]
11. [The OPG/RANKL/RANK system and bone resorptive disease].
Liu JZ; Ji ZL; Chen SM
Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):655-60. PubMed ID: 15971575
[TBL] [Abstract][Full Text] [Related]
12. B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo.
Li Y; Toraldo G; Li A; Yang X; Zhang H; Qian WP; Weitzmann MN
Blood; 2007 May; 109(9):3839-48. PubMed ID: 17202317
[TBL] [Abstract][Full Text] [Related]
13. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis.
Romas E; Gillespie MT; Martin TJ
Bone; 2002 Feb; 30(2):340-6. PubMed ID: 11856640
[TBL] [Abstract][Full Text] [Related]
14. Endogenous parathyroid hormone-related protein compensates for the absence of parathyroid hormone in promoting bone accrual in vivo in a model of bone marrow ablation.
Zhu Q; Zhou X; Zhu M; Wang Q; Goltzman D; Karaplis A; Miao D
J Bone Miner Res; 2013 Sep; 28(9):1898-911. PubMed ID: 23716486
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation.
Lee SK; Lorenzo JA
Endocrinology; 1999 Aug; 140(8):3552-61. PubMed ID: 10433211
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D and bone.
Suda T; Ueno Y; Fujii K; Shinki T
J Cell Biochem; 2003 Feb; 88(2):259-66. PubMed ID: 12520524
[TBL] [Abstract][Full Text] [Related]
17. Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis?
Avbersek-Luznik I; Balon BP; Rus I; Marc J
Nephrol Dial Transplant; 2005 Mar; 20(3):566-70. PubMed ID: 15665031
[TBL] [Abstract][Full Text] [Related]
18. Regulation of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase a pathway in murine bone marrow cultures.
Lee SK; Lorenzo JA
Bone; 2002 Jul; 31(1):252-9. PubMed ID: 12110442
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone and its related peptides in bone metabolism.
Chen T; Wang Y; Hao Z; Hu Y; Li J
Biochem Pharmacol; 2021 Oct; 192():114669. PubMed ID: 34224692
[TBL] [Abstract][Full Text] [Related]
20. IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells.
Toraldo G; Roggia C; Qian WP; Pacifici R; Weitzmann MN
Proc Natl Acad Sci U S A; 2003 Jan; 100(1):125-30. PubMed ID: 12490655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]